Porcine Vaccines Market to Reach USD 3.9 Billion by 2034

Pune, India, November 11, 2025 - The global Porcine Vaccines Market is projected to grow from USD 2.3 billion in 2024 to USD 3.9 billion by 2034, registering a CAGR of 5.4 %, according to Exactitude Consultancy. Rising outbreaks of swine infectious diseases, tightening biosecurity standards, and growing investments in veterinary immunization programs are fueling market expansion across Asia, Europe, and North America.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49123

Key Takeaways
• Market Size (2024): USD 2.3 billion
• Forecast (2034): USD 3.9 billion
• CAGR (2025-2034): 5.4 %
• Leading Companies: Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Ceva Santé Animale, Hipra, Vaxxinova, Indian Immunologicals Ltd., Biogénesis Bagó, and Phibro Animal Health.
• Top Applications: Swine influenza, porcine reproductive & respiratory syndrome (PRRS), mycoplasma, and circovirus immunization.

Market Story
Porcine vaccines are essential for preventing economically devastating diseases that impact global pork production. Growing demand for safe and high-yield livestock production, along with the need to reduce antibiotic usage, is strengthening the adoption of preventive vaccination strategies.

Governments and farm cooperatives are investing heavily in mass immunization programs to mitigate PRRS, classical swine fever, and African swine fever (ASF) threats. Meanwhile, biotech firms are developing DNA, mRNA, and recombinant vaccines that offer longer immunity and cross-strain protection.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/49123/porcine-vaccines-market

Market Segmentation
• By Vaccine Type:
o Inactivated Vaccines
o Live Attenuated Vaccines
o Recombinant Vaccines
o Toxoid Vaccines
o DNA Vaccines

• By Disease Indication:
o Swine Influenza
o PRRS (Porcine Reproductive & Respiratory Syndrome)
o Mycoplasma Hyopneumoniae
o Porcine Parvovirus
o Porcine Circovirus Type 2 (PCV2)
o Others

• By End User:
o Veterinary Hospitals & Clinics
o Swine Farms
o Government Agencies & Research Institutes

• By Region:
o Asia Pacific: Fastest-growing market due to high pork consumption and expanding commercial farms in China and Vietnam.
o North America: Strong R&D activity and high uptake of combination vaccines.
o Europe: Focus on eradicating ASF and complying with EU animal-health directives.
o Latin America & MEA: Improved veterinary infrastructure and government-subsidized vaccination drives.

Recent Developments
• 2025: Zoetis launched a bivalent ASF-PRRS prototype vaccine under early regulatory review in Europe.
• 2024: Merck Animal Health unveiled Porcilis PCV M Hyo Next Gen, a dual-protection vaccine offering extended immunity.
• 2023: Boehringer Ingelheim partnered with Ceva Santé Animale to develop recombinant ASF vaccines using viral-vector technology.
• 2022: Elanco Animal Health expanded production capacity in the U.S. to meet global swine vaccine demand.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49123

Expert Quote
"Global livestock biosecurity depends on strong immunization frameworks. The porcine vaccine sector is moving toward multi-valent, gene-based formulations that improve farm resilience and productivity," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.

Market Drivers
1. Increasing Swine Disease Outbreaks: Frequent PRRS and ASF incidents demand robust vaccination coverage.
2. Shift to Preventive Healthcare: Producers adopting vaccines to cut antibiotic dependency and improve yield.
3. Government and OIE Programs: Large-scale immunization initiatives in Asia and Latin America.
4. Advancements in Recombinant Technology: Faster vaccine development and broader strain coverage.

Forecast Outlook
Through 2034, the market will benefit from genetically engineered and thermostable vaccine platforms suitable for rural storage conditions. Increased automation in vaccine administration and rising collaborations between global pharma and regional veterinary institutes will further accelerate adoption.

Conclusion
The Porcine Vaccines Market stands at the intersection of biotechnology, food security, and sustainable livestock management. With continued innovation in antigen design and government-backed disease-control programs, the market is positioned for steady growth over the next decade.

This report is also available in the following languages : Japanese (豚ワクチン), Korean (돼지 백신), Chinese (猪疫苗), French (Vaccins porcins), German (Schweineimpfstoffe), and Italian (Vaccini suini), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49123

Our More Reports:

Healthcare Information Systems Market
https://exactitudeconsultancy.com/reports/49109/healthcare-information-systems-market

Healthcare Electronic Data Interchange Market
https://exactitudeconsultancy.com/reports/49112/healthcare-electronic-data-interchange-market

Dental Lasers Market
https://exactitudeconsultancy.com/reports/66982/dental-lasers-market

U.S. Veterinary Infusion Pumps Market
https://exactitudeconsultancy.com/reports/49118/veterinary-infu-s-ion-pumps-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.